#Gy

Related by string. #gy * * SN #gy *

Related by context. All words. (Click for frequent words.) 71 biochemical relapse 70 PSA nadir 70 chemoradiation therapy 69 cGy 69 postoperative chemotherapy 69 lumbar spine BMD 68 EBRT 68 total thyroidectomy 68 pT3 68 comparator arm 68 ABVD 67 locoregional recurrence 67 morphometric vertebral fractures 67 saline placebo 67 mCi 67 external beam radiotherapy 67 QTcF 67 4mg/kg 67 doxorubicin cyclophosphamide 67 CR nPR 67 mL/min/#.# m 2 67 Hazard Ratio HR 66 underwent surgical resection 66 lopinavir r arm 66 undetectable HBV DNA 66 Cystectomy 66 locoregional disease 66 placebo dexamethasone 66 FOLFOX6 66 Patency 66 adjuvant radiation 66 prostate carcinoma 66 % CI #.#-#.# [003] 66 transvaginal sonography 66 rFSH 66 NMIBC 66 mcg BID 66 SUVmax 66 preoperative chemotherapy 66 debulking surgery 66 clodronate 66 radiotherapy RT 66 5-FU/LV 66 nondiabetic patients 66 oxycodone CR 66 gadolinium enhanced 66 #mg BID [001] 66 IFN alfa 66 folinic acid 66 MBq 65 #mmHg [001] 65 radical nephrectomy 65 8mg/kg 65 sonographically guided 65 Doxil ® 65 colorectal adenoma 65 adjunctive placebo 65 euthyroid 65 Flu Cy 65 oral clodronate 65 complete cytogenetic response 65 chemoradiotherapy 65 nonmetastatic 65 Folfox 65 carboplatin paclitaxel 65 neutrophil counts 65 baseline LDH 65 REYATAZ r arm 65 leukocyte count 65 cytoreduction 65 radioiodine therapy 65 transaminase elevations 65 abacavir lamivudine 65 localized renal 65 invasive carcinomas 65 relapsed MM 65 multivariable adjusted 65 daily subcutaneous injections 65 advanced adenoma 65 transabdominal 65 revascularizations 65 methotrexate monotherapy 65 Chemoradiation 65 FOLFOX4 65 radial artery grafts 65 pCR 65 ertapenem 65 cytoreductive surgery 65 creatinine ratio 65 preoperative PSA 65 adriamycin 65 p = NS 64 severe neutropenia 64 liver metastasis 64 hip BMD 64 dalteparin 64 % CI #.#-#.# [007] 64 intra articular injection 64 hemodynamically significant 64 nephrectomy 64 metastatic malignant 64 ibandronate 64 HBeAg seroconversion 64 achieved ACR# 64 extracapsular extension 64 pegylated liposomal doxorubicin 64 VATS lobectomy 64 locoregional 64 underwent resection 64 mmol kg 64 abdominal computed tomography 64 Viread Emtriva Sustiva 64 fluorouracil leucovorin 64 -#.# log# 64 lymphadenectomy 64 femoral shaft fracture 64 nicardipine 64 flutamide 64 advanced adenomas 64 % Confidence Interval 64 P = .# 64 interferon ribavirin 64 TPV r 64 CCyR 64 ALT elevation 64 urothelial 64 -#.# ± [002] 64 pegylated interferon alfa 2b 64 atorvastatin #mg 64 μg kg 64 mucinous 64 FDG-PET/CT 64 Peg IFN 64 octreotide LAR 64 PRADAXA #mg 64 μmol L 64 PSADT 64 graft occlusion 64 recurrent metastatic 64 endometrial thickness 64 LPV r 64 tumor resection 64 Endometrial 64 tenecteplase 64 postop 64 Adjuvant chemotherapy 64 cellularity 64 CIN3 64 Kaplan Meier 64 unfractionated heparin UFH 64 tricuspid regurgitation 64 pT2 64 biliary tract cancer 64 paricalcitol 64 #.#ng/ml 64 #mg/day [002] 63 fatty infiltration 63 FDG uptake 63 â ‰ ¥ 63 microgram kg 63 nmol 63 thyroglobulin 63 carotid artery intima media 63 TURP 63 lopinavir r 63 PASI scores 63 histologic subtype 63 hypofractionated 63 TKAs 63 mg m² 63 baseline Hb 63 haematologic 63 KRAS mutations occur 63 leiomyomas 63 neoadjuvant therapy 63 oxycodone IR 63 histologically proven 63 stage IIIb IV 63 antithymocyte globulin 63 5-fluorouracil/leucovorin 63 epididymal 63 Angiographic 63 TURBT 63 neutropenic sepsis 63 FUSILEV enhances 63 HER2 expression 63 intratumoral 63 adjuvant radiotherapy 63 papillary renal cell carcinoma 63 Ultrasonography 63 hematologic toxicity 63 estramustine 63 Subgroup analysis 63 needle aspiration 63 Index CDAI 63 neurologic progression 63 intact parathyroid hormone 63 androgen suppression 63 p = #.# [003] 63 CI #.#-#.# [001] 63 contralateral breast 63 metastatic GIST 63 computed tomographic scan 63 serum creatinine levels 63 HoLEP 63 invasive lobular 63 paracentesis 63 hepatectomy 63 concurrent chemoradiation 63 RVOT 63 visceral metastases 63 paclitaxel carboplatin 63 Partial Response 63 submucosal 63 Postoperative 63 vaginal hysterectomy 63 polypoid 63 salmeterol fluticasone propionate 63 neoadjuvant chemotherapy 63 lymphocyte count 63 achieved CCyR 63 gross hematuria 63 postoperative complication 63 nodular partial response 63 doxorubicin docetaxel 63 Papillary 63 ARB telmisartan 63 orchiectomy 63 Postoperatively 63 #F FDG 63 operable breast cancer 63 Histologic 63 proximal tibial 63 mcg QD 63 5 Fluorouracil 63 subtrochanteric 63 CC genotype 63 elevated transaminases 63 conventional angiography 63 FOLFIRI alone 63 abdominal irradiation 63 zoledronate 63 lactate dehydrogenase 63 nadolol 63 intra arterial 63 multivariate Cox 63 pneumonectomy 63 FluCAM arm 63 titrated glipizide 63 ejection fractions 63 rosuvastatin #mg 63 para aortic 63 piperacillin tazobactam 62 Mitomycin C 62 computed tomographic 62 enucleation 62 Fluorouracil 62 recurrent glioblastoma multiforme 62 chemotherapy cisplatin 62 intravenous bolus injection 62 5 fluorouracil leucovorin 62 nadroparin 62 radiochemotherapy 62 abdominal hysterectomy 62 Duodenal 62 decompressive surgery 62 cisplatin chemotherapy 62 Pegylated Liposomal Doxorubicin 62 ureteroscopy 62 moderate renal impairment 62 axillary node 62 femoral neck fracture 62 dimensional echocardiography 62 intraventricular 62 plus medroxyprogesterone acetate 62 total abdominal hysterectomy 62 cystectomy 62 pamidronate 62 ASCUS 62 steroid dexamethasone 62 interobserver reliability 62 fluorouracil 62 renal tumors 62 tortuosity 62 infliximab monotherapy 62 HGPIN 62 corneal astigmatism 62 atheroma volume 62 μg liter 62 reinfarction 62 cisplatin gemcitabine 62 LV dysfunction 62 deep venous thromboses 62 3mg/kg 62 Zometa hazard 62 CI -#.# 62 mitoxantrone chemotherapy 62 #.#mg/dL 62 unfractionated heparin 62 gastrectomy 62 scleral buckling 62 budesonide pMDI 62 mg qd 62 renal pelvis 62 injected subcutaneously 62 mg TID 62 biopsy Gleason 62 intravitreal injections 62 neoplasias 62 vasopressor 62 confidence interval #.#-#.# 62 Preoperatively 62 LV ejection fraction 62 5FU 62 #mg dose [002] 62 Thal Dex 62 daunorubicin 62 BEACOPP 62 Ejection Fraction 62 endometrial biopsy 62 intraperitoneal injection 62 bolus injection 62 hypervascular 62 aspartate aminotransferase AST 62 ropivacaine 62 bypass grafting 62 mg ustekinumab 62 dyssynchrony 62 retroperitoneal 62 eosinophil count 62 receiving VICTRELIS 62 leiomyoma 62 CLL SLL 62 gastric cardia 62 logMAR 62 hepatic metastases 62 intima media thickness 62 colorectal carcinoma 62 PREZISTA ritonavir 62 CYPHER Stent 62 hydronephrosis 62 LEXIVA r 62 Histological 62 hypophosphatemia 62 CR CRu 62 transurethral resection 62 aspartate aminotransferase 62 microg 62 osteoporotic vertebral compression fractures 62 Pegylated Interferon 62 binary restenosis 62 melphalan prednisone 62 hemoglobin Hb 62 intravenous bolus 62 interferon alfa 2b 62 helical TomoTherapy 62 ultrasonographic 62 Leucovorin 62 FOLFOX4 alone 62 metaplasia 62 interquartile range 62 Retreatment 62 HOMA IR 62 mitoxantrone plus 62 tirofiban 62 epirubicin cyclophosphamide 62 colorectal liver metastases 62 Soft Tissue Sarcoma 62 percutaneous biopsy 62 NPH insulin 62 TAXOTERE R 62 systemic corticosteroid 62 CK MB 62 ALA PDT 62 liver histology 62 T1a 62 biochemical recurrence 62 mg/m2 dose 62 neurologic deficits 62 Ceplene/IL-2 62 lobectomy 62 somatostatin analog 62 CHOP chemotherapy 62 uL 62 postmenopausal osteoporotic women 62 cisplatin vinorelbine 62 generalized edema 62 androgen deprivation 62 umbilical artery 62 q#h 62 perioperatively 62 definite stent thrombosis 62 hematopoietic cancers 62 gemcitabine carboplatin 62 vitreous haze 62 resected pancreatic cancer 62 invasive ductal 62 abacavir Ziagen 62 chemoembolization 62 mild renal insufficiency 62 parathyroidectomy 62 infarct size 61 fallopian tube carcinoma 61 Xelox 61 Breast conserving 61 FOLFIRI 61 zonisamide SR 61 helical CT 61 histologically confirmed 61 aspirin clopidogrel 61 alanine aminotransferase ALT 61 photocoagulation 61 systemic hypotension 61 tumor excision 61 ribavirin RBV 61 transurethral 61 bolus dose 61 Median PFS 61 antibody titer 61 anterior uveitis 61 lymph node metastasis 61 mcg albinterferon alfa 2b 61 atazanavir ritonavir 61 diaphysis 61 glomerular filtration 61 Platinol ® cisplatin 61 lamivudine monotherapy 61 malignancy HCM 61 colorectal adenocarcinoma 61 PEG IFN 61 cilostazol 61 noninferior 61 intravesical therapy 61 surgical resection cavity 61 mcg mL 61 artery stenosis 61 penetrating keratoplasty 61 hMG 61 acetazolamide 61 MR Angiography 61 neostigmine 61 μg d 61 hepatorenal syndrome 61 thrombus aspiration 61 mL/min/#.# m2 61 monophasic 61 splenic 61 unresectable tumors 61 #mg/m# [002] 61 mIU ml 61 resectable 61 periocular 61 histopathologic examination 61 otamixaban 61 leuprorelin 61 ductal cancer 61 ventricular myocardium 61 ‰ ¥ 61 adrenalectomy 61 lymphocytosis 61 sonographically 61 adjuvant cisplatin 61 neoadjuvant 61 F FDG PET 61 Am J Cardiol 61 idraparinux 61 β blockers 61 Adenomas 61 Legg Calvé Perthes disease 61 pulmonary resection 61 gadolinium enhancing lesions 61 Coronary Artery Bypass Graft 61 Ishak fibrosis score 61 papillary thyroid carcinoma 61 pulmonary metastasis 61 sacrocolpopexy 61 ACR# responses 61 intraabdominal 61 transthoracic 61 response CCyR 61 q8h 61 echogenicity 61 myocardial viability 61 plus dexamethasone 61 ug ml 61 peritumoral 61 intraductal 61 MMSE score 61 interferon alfa 2a 61 IELT 61 resected 61 urothelial carcinoma 61 median survivals 61 Breslow thickness 61 Mg Uk 61 endometrial hyperplasia 61 endoscopic resection 61 undergoing coronary artery 61 vastus lateralis 61 Free Survival PFS 61 Gy 61 Intravitreal 61 paclitaxel eluting stents 61 T2 lesion volume 61 wedge resection 61 NSTE ACS 61 Kaplan Meier analysis 61 postoperative radiographs 61 squamous cell carcinoma SCC 61 Adjuvant Treatment 61 diagnostic angiography 61 endometrial carcinoma 61 #OHD 61 pmol L 61 stent stenosis 61 ritonavir boosted 61 pharmacologically active isomer 61 nonischemic 61 nonmetastatic prostate cancer 61 intravenous diuretics 61 spine BMD 61 opacification 61 Prostatic 61 Metastatic Prostate Cancer 61 fractional shortening 61 normothermic 61 biopsy specimen 61 PHPT 61 primary patency 61 esophagectomy 61 Pemetrexed 61 perioperative morbidity 61 transarterial 61 bone scintigraphy 61 intermittent hemodialysis 61 tolterodine ER 61 p = ns 61 underwent radical prostatectomy 61 postoperative radiotherapy 61 surgical debulking 61 ductal lobular 61 nonvertebral 61 oral prednisone 61 salmeterol fluticasone 61 docetaxel prednisone 61 serum aminotransferase levels 61 mutated K ras 61 % CI #.#-#.# [001] 61 percutaneous vertebroplasty 61 conduction velocity 61 OPCAB 61 bivalirudin monotherapy 61 bronchoalveolar lavage 61 vertebrobasilar 61 receiving ISENTRESS 61 eplerenone 61 specific antigen PSA 61 lumbar spine bone 61 calcaneal fractures 61 lavage 61 transaminase levels 61 intravenous bisphosphonates 61 symptomatic intracranial 61 gastroesophageal junction 61 submandibular gland 61 femoral head 61 anteroposterior 61 transection 61 plus methotrexate 61 multivariable analysis 61 Thrombolysis 61 rFVIIa 61 femoral neck BMD 61 ALND 61 CIN2 + 61 mCi kg 61 OGTT 61 Peginterferon 61 TLUS 61 intraobserver 61 ipsilateral 61 mRCC 61 chemo radiotherapy 61 QRS duration 61 timepoints 61 Hypotension 61 #mg/kg [002] 61 subcutaneous enoxaparin 61 renal artery stenting 61 asymptomatic carotid stenosis 61 pyridostigmine 61 transfusion syndrome 61 mL kg 61 patients undergoing CABG 61 pancreatic adenocarcinoma 61 ug mL 61 uM 61 arteriography 61 dose dexamethasone 61 pleural fluid 61 bladder tumors 61 perioperative complications 61 certolizumab 61 ESWL 61 μg L 61 ritonavir boosted atazanavir 61 intradermal injections 61 hip resurfacing arthroplasty 61 remission CR 61 serum urate levels 61 mg kg dose 61 sUA 61 dacarbazine DTIC 61 deferoxamine 61 resections 60 percutaneous nephrolithotomy 60 postintervention 60 TRUS 60 pathologic diagnosis 60 aplasia 60 completely resected 60 oral allopurinol 60 urethral strictures 60 lesional 60 posterolateral fusion 60 prospectively stratified 60 mg QD 60 lumbar lordosis 60 #mg/m# [001] 60 abdominal circumference 60 hyperinsulinemic euglycemic clamp 60 imiquimod cream 60 hyperintensity 60 ug kg 60 arteriolar 60 pelvic lymphadenectomy 60 histological subtype 60 oral diclofenac 60 antiretroviral naïve 60 gastroduodenal 60 radical prostatectomy RP 60 partial remissions 60 severe mitral regurgitation 60 argatroban 60 superficial femoral 60 everolimus eluting stents 60 retropubic 60 Cyclophosphamide 60 Toxicities 60 postprocedure 60 statistically significant p = 60 azacytidine 60 histopathologic findings 60 irinotecan chemotherapy 60 lenalidomide dexamethasone 60 metastatic malignant melanoma 60 nonoperative treatment 60 triiodothyronine 60 LVEF 60 venography 60 osteopenic 60 dose atorvastatin 60 interferon α 60 epithelial ovarian 60 supraclavicular 60 GORE TAG Device 60 Gliadel Wafer 60 GnRH agonist 60 salpingo oophorectomy 60 esophageal carcinoma 60 alfa 2a 60 Patients Receiving 60 MACCE 60 ischemia driven 60 cranial irradiation 60 unresectable HCC 60 anagrelide 60 EDSS scores 60 antiandrogen 60 thrombocytopenic 60 imipenem 60 distal radial fractures 60 hematological relapse 60 Hormone Refractory Prostate Cancer 60 leucopenia 60 achieved mucosal healing 60 Irinotecan 60 urolithiasis 60 baseline FEV 60 Bankart lesion 60 androgen ablation 60 Operative mortality 60 ^ sup #m 60 tracer uptake 60 carotid artery thickness 60 basal cell carcinoma BCC 60 underwent radical cystectomy 60 carotid artery blockage 60 cardioplegic arrest 60 CT coronary angiography 60 inotropic agents 60 interstitial brachytherapy 60 #.#g/day 60 hypogonadal 60 retransplantation 60 distal clavicle 60 CK # administered 60 oral rivaroxaban 60 pathologic examination 60 grade squamous intraepithelial 60 papillary carcinoma 60 #.#/#.# mmHg [001] 60 #mg ATC 60 tPSA 60 thromboembolic 60 Ischemic 60 cardiac perfusion 60 intracapsular 60 p ≤ 60 chest radiographs 60 invasive angiography 60 aortic insufficiency 60 Decitabine 60 hypoperfusion 60 Partial Responses 60 PREZISTA r arm 60 obstructive CAD 60 lactate dehydrogenase LDH 60 paroxysmal AF 60 pulmonary artery banding 60 lumbar disc herniation 60 Paraplatin ® 60 #.#/#.# mm Hg [003] 60 electrical cardioversion 60 biologic DMARD 60 serum sodium levels 60 + PH# 60 mitral annular 60 cerebral vasospasm 60 Peripheral Arterial 60 proximal humerus 60 randomized multicenter trial 60 adenoma detection 60 squamous carcinoma 60 orchidectomy 60 serum estradiol 60 HBeAg negative 60 Patients Undergoing 60 Hgb 60 T2 weighted MRI 60 radical cystectomy 60 sarcomatoid 60 Doppler sonography 60 Resection 60 surgically resected 60 transrectal 60 liposomal doxorubicin 60 proximal femur 60 ATV RTV 60 mutated KRAS 60 myocardial reperfusion 60 plus GP IIb 60 colorectal neoplasms 60 perioperative mortality 60 cyclophosphamide doxorubicin vincristine 60 infarcts 60 sirolimus eluting stent 60 corifollitropin alfa 60 ovarian carcinoma 60 GH deficiency 60 MADRS score 60 indinavir 60 atrioventricular block 60 postoperative hemorrhage 60 intestinal metaplasia 60 thalidomide dexamethasone 60 EUS FNA 60 Lumbar spine 60 colon resection 60 #mg #mg #mg [003] 60 cerebrovascular events 60 tipranavir ritonavir 60 hypointense 60 postoperative pulmonary 60 pulmonary angiography 60 aminotransferase ALT 60 insulin detemir 60 intracerebral 60 hilar 60 mU liter 60 iPTH 60 HSCT 60 kilogram mg kg 60 epoetin alpha 60 variceal hemorrhage 60 arteriovenous fistula 60 artery embolization 60 metastatic gastric 60 dacarbazine chemotherapy 60 oblimersen 60 dosing cohort 60 plus 5-FU/LV 60 Figure 2C 60 intravenous REOLYSIN 60 serum TSH 60 undergone radical prostatectomy 60 Kyphoplasty 60 ALT elevations 60 Follicular Lymphoma 60 collagenous colitis 60 Peginterferon Alfa 2a 60 nmol l 60 prospectively defined 60 postoperative morbidity 60 Kaplan Meier method 60 leukopenia 60 intra arterial chemotherapy 60 epirubicin 60 tamsulosin 60 axillary node dissection 60 percutaneous drainage 60 left ventricular systolic 60 palifermin 60 #mg QD [002] 60 TIMP 1 60 gemcitabine cisplatin 60 pulmonary dysfunction 60 distal femur 60 T2 lesions 60 urinary N telopeptide 60 chemotherapy docetaxel 60 hepatic vein 60 #mg/day [001] 60 Stereotactic Body Radiation Therapy 60 infusional 60 SLNB 60 ara C 60 ischemic lesions 60 deoxy 60 polyp recurrence 60 cinacalcet 60 aminotransferases 60 intensity modulated radiotherapy IMRT 60 Surgical excision 60 prospectively randomized 60 #mg dosing 60 serum testosterone 60 NAVISTAR R 60 #ug [002] 60 axillary lymph nodes 60 peritoneal carcinomatosis 60 intramuscular injections 60 cervical lymph nodes 60 #.#-#.# [011] 60 prednisone prednisolone plus 60 aneurysmal 60 intravenous cyclophosphamide 60 DAS# remission 60 Fig. 3b 60 Naive Patients 60 parenchymal 60 liver biopsies 59 hip femoral neck 59 endarterectomy 59 CIMZIA TM 59 thyroidectomy 59 H. pylori eradication 59 goserelin 59 multicenter randomized controlled 59 mycophenolate mofetil 59 fluoroscopically guided 59 SGPT 59 P ≤ 59 cyclophosphamide methotrexate 59 AZT zidovudine Retrovir 59 axillary dissection 59 TACE 59 % CI #.#-#.# [008] 59 IM progesterone 59 proximal tibia 59 aortic regurgitation 59 hours postdose 59 ureteric 59 nonmelanoma skin cancers 59 radiographic findings 59 Carotid artery 59 Radical prostatectomy 59 NNT = 59 vincristine doxorubicin 59 Pred Forte 59 Adjuvant therapy 59 IFN α 59 FOLPI 59 NIHSS 59 Fludarabine 59 LNG IUS 59 total knee arthroplasties 59 laser photocoagulation 59 reflux esophagitis 59 transient elastography 59 SSc 59 full thickness plication 59 gastric adenocarcinoma 59 IOP lowering 59 non splenectomized 59 vitreous floaters 59 ipsilateral stroke 59 lymph node involvement 59 EGFR TKI 59 elevated LDH 59 fibroma 59 NYHA functional class 59 hemodynamically 59 thromboembolic complications 59 cough dyspnea 59 recombinant FSH 59 tibial shaft 59 mdx mice 59 DEXA scans 59 angiographic outcomes 59 mCi m 2 59 renal cell carcinomas 59 Stage IIIb 59 receiving highly emetogenic 59 ug dose 59 ^ Tc 59 periprocedural 59 recurrent venous thromboembolism 59 Hypertrophy 59 isoprostane 59 Adjunctive 59 cerebral angiography 59 posttreatment 59 dosimetric 59 ischemic mitral regurgitation 59 alanine aminotransferase 59 tolvaptan 59 peginterferon alpha 2a 59 glycated hemoglobin levels 59 linoleic acid LA 59 intramuscularly 59 p# biomarker 59 severe oral mucositis 59 endometrioid 59 irbesartan 59 anastrazole 59 glulisine 59 amoxicillin clavulanate 59 prednisone prednisolone 59 anthracycline taxane 59 isoenzyme 59 IV bisphosphonates 59 cefazolin 59 intensity modulated radiotherapy 59 primary percutaneous coronary 59 pg mL 59 lispro 59 resectable pancreatic cancer 59 prostate TURP 59 subacromial 59 pairwise comparisons 59 neointimal 59 atrial pacing 59 symptomatic carotid stenosis 59 cardiopulmonary bypass CPB 59 Patients Treated With 59 confidence intervals CIs 59 captopril 59 care regimens CCR 59 carotid stenosis 59 nodal metastasis 59 T1 weighted 59 weekly intravenous infusions 59 χ 59 eptifibatide 59 intracavitary 59 rhTSH 59 contralateral 59 inotropic 59 FFNS 59 functional mitral regurgitation 59 Q2W 59 postoperative mortality 59 adenoma recurrence 59 nodal metastases 59 Natalizumab 59 RARP 59 hemoptysis 59 XELOX 59 transferrin saturation 59 preintervention 59 weekly subcutaneous injections 59 chlorambucil 59 fumagillin nanoparticles 59 Common Toxicity Criteria 59 paclitaxel cisplatin 59 HbA 1c levels 59 Response Evaluation Criteria 59 leukocytosis

Back to home page